Bile Acids in Hepatobiliary Disease [Hardcover]

This book is the proceedings of the Falk Workshop on `Bile Acids in Hepatobiliary Disease', which took place at the Royal Society of Medicine (RSM) in London, UK, on 29-30 March 1999, and was held in association with the Section of Measurement in Medicine at the RSM.
The main interest in bile acid therapy has been recently in cholestatic liver disease. The proceedings of the workshop not only discusses this, but moves on to examine its possible use in alcoholic liver disease, and moves back to re-examine its role in biliary disease. Leading world experts attempt to define its mechanism of action, and the current role of other non-surgical treatments in biliary disease. The physiology and pathogenesis of cholestatic and alcoholic liver disease and cholesterol gallstone disease is also examined.Preface. List of Contributors. 1. Introduction; T.C. Northfield. Section I: Cholestatic Liver Disease: Physiology, Pathogenesis and Epidemiology. 2. Cellular and Molecular Mechanisms of Bile Salt Transport in Health and Disease; J.L. Boyer. 3. Biochemical Aspects; J. Reichen. 4. Immunological Aspects; M.F. Bassendine. Section II: Bile Acid Therapy. 5. Optimum Dose of UDCA in Primary Biliary Cirrhosis (PBC); A. Verma. 6. Ursodeoxycholic Acid - An Immunomodulator in Primary Biliary Cirrhosis? A.G. Lim, et al. Section III: Clinical Trials. 7. Primary Biliary Cirrhosis: Long-Term Management with Ursodeoxycholic Acid; J. Heathcote. &lC&